Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 VaccineStephen J. Thomas, Kathrin U. Jansen, John L. Perez et al.|medRxiv|2021Cited by 144
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of <i>Clostridioides difficile</i> InfectionCurtis J. Donskey, Nicholas Kitchin, Erik R. Dubberke et al.|Clinical Infectious Diseases|2024Cited by 37
Plain Language Summary of Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Safety in Participants at Least 16 Years Old and Protection Against COVID-19 in Participants at Least 12 Years OldStephen J. Thomas, Kathrin U. Jansen, Edson Duarte Moreira et al.|Future Virology|2022Cited by 0